"HIV Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens.
| Descriptor ID |
D015488
|
| MeSH Number(s) |
D23.050.327.520
|
| Concept/Terms |
HIV Antigens- HIV Antigens
- Antigens, HIV
- AIDS Antigens
- Antigens, AIDS
- HIV Associated Antigens
- Antigens, HIV Associated
- Associated Antigens, HIV
- HIV-Associated Antigens
- Antigens, HIV-Associated
- HTLV III Antigens
- Antigens, HTLV III
- III Antigens, HTLV
- T Lymphotropic Virus Type III Antigens, Human
- HTLV III LAV Antigens
- HTLV-III-LAV Antigens
- Antigens, HTLV-III-LAV
- LAV Antigens
- Antigens, LAV
- Lymphadenopathy Associated Antigens
- Antigens, Lymphadenopathy Associated
- Associated Antigens, Lymphadenopathy
- Lymphadenopathy-Associated Antigens
- Antigens, Lymphadenopathy-Associated
- T-Lymphotropic Virus Type III Antigens, Human
- HTLV-III Antigens
- Antigens, HTLV-III
|
Below are MeSH descriptors whose meaning is more general than "HIV Antigens".
Below are MeSH descriptors whose meaning is more specific than "HIV Antigens".
This graph shows the total number of publications written about "HIV Antigens" by people in this website by year, and whether "HIV Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 11 | 12 | 23 |
| 2018 | 10 | 7 | 17 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Antigens" by people in Profiles.
-
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa. Sci Transl Med. 2019 09 18; 11(510).
-
Analytical performance evaluation and enhancement of the ADVIA Centaur® HIV Ag/Ab Combo assay. J Clin Virol. 2019 09; 118:36-40.
-
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. Hematol Oncol. 2019 Apr; 37(2):176-184.
-
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation. Lab Invest. 2019 02; 99(2):180-190.
-
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants. Biochim Biophys Acta Gen Subj. 2019 01; 1863(1):13-24.
-
Structure of the membrane proximal external region of HIV-1 envelope glycoprotein. Proc Natl Acad Sci U S A. 2018 09 18; 115(38):E8892-E8899.
-
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates. J Clin Microbiol. 2018 08; 56(8).
-
Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. Cell Host Microbe. 2018 06 13; 23(6):832-844.e6.
-
Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. PLoS Pathog. 2018 05; 14(5):e1006986.
-
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant. PLoS One. 2018; 13(4):e0194266.